ConductScience.org, home

Paper9083

Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.

Duarte-Karim M and 2 others. Biochem Biophys Res Commun, 1976. Cited by 136 papers, by iCite.

Cite this record

ConductScience Library. Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions. Papers, record 9083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9083

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions.
PubMed
Journal
Biochem Biophys Res Commun
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
136
iCite
Relative citation ratio, by iCite
5.26
iCite
Revised in PubMed
2019-06-12
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Duarte-Karim MM
2Ruysschaert JMJ M
3Hildebrand JJ

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DoxorubicinMajor topic
Mitochondria, MuscleMajor topic
MyocardiumMajor topic
PhospholipidsMajor topic
Animals
Binding Sites
Cardiolipins
DNA
Hydrogen-Ion Concentration
Kinetics
Models, Biological

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 136 citations.

PMIDTitleJournalYearIn PapersSource
37175395Exercise and Doxorubicin Modify Markers of Iron Overload and Cardiolipin Deficiency in Cardiac Mitochondria.Int J Mol Sci2023https://conductscience.org/library/papers/37175395PubMed
34587760Cardiotoxicity of Cancer Treatments: Focus on Anthracycline Cardiomyopathy.Arterioscler Thromb Vasc Biol2021https://conductscience.org/library/papers/34587760PubMed
19002786Intracellular distribution of anthracyclines in drug resistant cells.Cytotechnology1998https://conductscience.org/library/papers/19002786PubMed
12841626The influence of lipoic acid on adriamycin induced nephrotoxicity in rats.Mol Cell Biochem2003https://conductscience.org/library/papers/12841626PubMed
9929491Binding of adriamycin to liposomes as a probe for membrane lateral organization.Biophys J1999https://conductscience.org/library/papers/9929491PubMed
8970871Noninvasive monitoring of intraocular pharmacokinetics of daunorubicin using fluorophotometry.Int Ophthalmol1995https://conductscience.org/library/papers/8970871PubMed
7274305Differential adriamycin distribution to blood components.Eur J Drug Metab Pharmacokinet1981https://conductscience.org/library/papers/7274305PubMed
6940195Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6940195PubMed
6378238Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.Br J Cancer1984https://conductscience.org/library/papers/6378238PubMed
4006046Lysosomal alterations in heart and liver of mice treated with doxorubicin.Cancer Chemother Pharmacol1985https://conductscience.org/library/papers/4006046PubMed
3742710Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3742710PubMed
3412115Membrane lipid alteration: effect on cellular uptake of mitoxantrone.Lipids1988https://conductscience.org/library/papers/3412115PubMed
3370735Selectivity of the anthracyclines for negatively charged model membranes: role of the amino group.Cancer Chemother Pharmacol1988https://conductscience.org/library/papers/3370735PubMed
2822273A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroids.Cancer Chemother Pharmacol1987https://conductscience.org/library/papers/2822273PubMed
2432879Conformation and mode of organization of amphiphilic membrane components: a conformational analysis.Biochem J1986https://conductscience.org/library/papers/2432879PubMed
1937080Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.Graefes Arch Clin Exp Ophthalmol1991https://conductscience.org/library/papers/1937080PubMed
1366656Doxorubicin effects on contractile structures and molecules.Cytotechnology1990https://conductscience.org/library/papers/1366656PubMed
373905Cardiotoxic effects of antitumor agents.Cancer Chemother Pharmacol1978https://conductscience.org/library/papers/373905PubMed
348587Anthracyclines--modern tumour-inhibiting agents.Folia Microbiol (Praha)1978https://conductscience.org/library/papers/348587PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9083

GET https://conductscience.org/api/papers/v1/9083/authors